[Federal Register Volume 68, Number 63 (Wednesday, April 2, 2003)]
[Notices]
[Page 16088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-7838]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By notice dated March 12, 2002, and published in the Federal 
Register on March 25, 2002 (67 FR 13664), Chiragene, Inc., 7 Powder 
Horn Drive, Warren, New Jersey 07059, made application by renewal to 
the Drug Enforcement Administration (DEA) to be registered as an 
importer of phenylacetone (8501), a basic class of controlled substance 
listed in Schedule II. The Company's legal name has since changed to 
Cambrex North Brunswick, Incorporated.
    The firm plans to import phenylacetone to manufacture amphetamine.
    Objections and a request for hearing were timely filed and then 
withdrawn. DEA has considered the factors in title 21, United States 
Code, section 823(a) and determined that the registration of Cambrex 
North Brunswick, Inc., to import phenylacetone is consistent with the 
public interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Cambrex North Brunswick, Inc. on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. These investigations have included inspection 
and testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to section 1008(a) of the Controlled Substances 
Import and Export Act and in accordance with title 21, Code of Federal 
Regulations, section 1301.34, the above firm is granted registration as 
an importer of the basic class of controlled substance listed.

    Dated: March 14, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-7838 Filed 4-1-03; 8:45 am]
BILLING CODE 4410-09-M